Loading...
Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma
Drug resistance and disease recurrence are important contributors for the poor prognosis of glioblastoma multiforme (GBM). Temozolomide (TMZ), the standard chemotherapy for GBM treatment, can methylate DNA and cause the formation of double-strand breaks (DSBs). X-ray repair cross complementing 5 (XR...
Na minha lista:
| Udgivet i: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8045174/ https://ncbi.nlm.nih.gov/pubmed/33868481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12704 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|